Clinical Trials Directory

Trials / Completed

CompletedNCT06606652

Caffeine, Resistance Exercise and EMG

Effect of Acute Caffeine Intake on Muscle Electrical Activity and Muscular Strength, Power, and Endurance Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Alcala · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Introduction: Several studies have evaluated and confirmed the ergogenic effects of acute caffeine intake on sports performance. However, some studies suggest that this effect predominantly occurs in large muscle groups, potentially due to increased skeletal muscle electrical activity. Objectives: This study aims to evaluate the acute effects of caffeine intake on strength, power, muscle endurance, and muscle electrical activity in young adults. It will also analyze the influence of circadian rhythms (morning vs. afternoon) on exercise performance (bench press vs. squat). Methods: Twelve healthy, physically active participants will be recruited for the study. Using a triple-blind, crossover, randomized, and controlled design, participants will ingest either caffeine (3 mg/kg body mass) or a placebo (maltodextrin, 3 mg/kg) 60 minutes before the trial. Muscular strength, power, and endurance performance will then be assessed through 1RM tests, and at 25%, 50%, 75%, and 90% of 1RM, along with muscle endurance tests at 65% of 1RM, for both squat and bench press exercises. EMG will be used to measure skeletal muscle electrical activity during the tests. The experimental sessions will be conducted in the morning (8:00 am to 10:00 am) and the afternoon (4:30 pm to 6:30 pm).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeineAcute caffeine intake (3 mg/kg)
DIETARY_SUPPLEMENTPlaceboAcute placebo intake (3 mg/kg of maltodextrin)

Timeline

Start date
2023-09-01
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2024-09-23
Last updated
2024-09-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06606652. Inclusion in this directory is not an endorsement.